Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application

Roberts, E., Cossigny, D. A. F., & Quan, G. Y. (2013). The Role of Vascular Endothelial Growth Factor in Metastatic Prostate Cancer to the Skeleton. Prostate Cancer, 2013(), 51-58. https://doi.org/10.1155/2013/418340
童郁琇、劉淑貞（2022）。Nephrotoxicity of Vascular Endothelial Growth Factor Inhibitors。臺灣臨床藥學雜誌，30(3)，217-224。https://doi.org/10.6168/FJCP.202207_30(3).0004
Chung, P. C., Lu, L. Y., Yen, L. J., Keng, H. M., Hu, J. C., Wang, L. F., Chu, J. J., Hsu, C. M., Lin, X. T., & Tseng, J. C. (2012). Vascular Endothelial Growth Factor and Endostatin in Synovial Fluid of Various Arthritic Conditions. Formosan Journal of Rheumatology, 26(1&2), 86-91. https://doi.org/10.6313/FJR.2012.26(1-2).12
Corlan, A. S., Cîmpean, A. M., Jitariu, A. A., Melnic, E., & Raica, M. (2017). Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis. International Journal of Endocrinology, 2017(), 1-13. https://doi.org/10.1155/2017/3232905
謝琬汝（2011）。Vascular endothelial growth factor antibody conjugated iron oxide nanoparticles for in vivo tumor targeting and imaging〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU.2011.00644